Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 15:36:42 UTC |
---|
Update Date | 2021-09-26 23:10:53 UTC |
---|
HMDB ID | HMDB0255769 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Ilginatinib |
---|
Description | SCHEMBL22806851 belongs to the class of organic compounds known as aminopyrazines. These are organic compounds containing an amino group attached to a pyrazine ring. Based on a literature review very few articles have been published on SCHEMBL22806851. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ilginatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ilginatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(NC1=CC(=CC(NC2=NC=CN=C2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C1 InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H20FN7 |
---|
Average Molecular Weight | 389.438 |
---|
Monoisotopic Molecular Weight | 389.176421835 |
---|
IUPAC Name | N2-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-(pyrazin-2-yl)pyridine-2,6-diamine |
---|
Traditional Name | N2-[1-(4-fluorophenyl)ethyl]-4-(1-methylpyrazol-4-yl)-N6-(pyrazin-2-yl)pyridine-2,6-diamine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(NC1=CC(=CC(NC2=NC=CN=C2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C1 |
---|
InChI Identifier | InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28) |
---|
InChI Key | UQTPDWDAYHAZNT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminopyrazines. These are organic compounds containing an amino group attached to a pyrazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrazines |
---|
Direct Parent | Aminopyrazines |
---|
Alternative Parents | |
---|
Substituents | - Secondary aliphatic/aromatic amine
- Halobenzene
- Fluorobenzene
- Aminopyridine
- Aminopyrazine
- Imidolactam
- Benzenoid
- Pyridine
- Monocyclic benzene moiety
- Aryl halide
- Aryl fluoride
- Heteroaromatic compound
- Pyrazole
- Azole
- Azacycle
- Secondary amine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 194.437 | 30932474 | DeepCCS | [M-H]- | 192.079 | 30932474 | DeepCCS | [M-2H]- | 226.085 | 30932474 | DeepCCS | [M+Na]+ | 201.209 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ilginatinib,1TMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C | 3519.8 | Semi standard non polar | 33892256 | Ilginatinib,1TMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C | 3438.0 | Standard non polar | 33892256 | Ilginatinib,1TMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C | 5063.3 | Standard polar | 33892256 | Ilginatinib,1TMS,isomer #2 | CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)C1=CC=C(F)C=C1 | 3456.5 | Semi standard non polar | 33892256 | Ilginatinib,1TMS,isomer #2 | CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)C1=CC=C(F)C=C1 | 3443.7 | Standard non polar | 33892256 | Ilginatinib,1TMS,isomer #2 | CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)C1=CC=C(F)C=C1 | 4686.5 | Standard polar | 33892256 | Ilginatinib,2TMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)[Si](C)(C)C | 3388.3 | Semi standard non polar | 33892256 | Ilginatinib,2TMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)[Si](C)(C)C | 3377.3 | Standard non polar | 33892256 | Ilginatinib,2TMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)[Si](C)(C)C | 4393.2 | Standard polar | 33892256 | Ilginatinib,1TBDMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C(C)(C)C | 3741.4 | Semi standard non polar | 33892256 | Ilginatinib,1TBDMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C(C)(C)C | 3627.7 | Standard non polar | 33892256 | Ilginatinib,1TBDMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C(C)(C)C | 5121.8 | Standard polar | 33892256 | Ilginatinib,1TBDMS,isomer #2 | CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)C1=CC=C(F)C=C1 | 3632.0 | Semi standard non polar | 33892256 | Ilginatinib,1TBDMS,isomer #2 | CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)C1=CC=C(F)C=C1 | 3565.2 | Standard non polar | 33892256 | Ilginatinib,1TBDMS,isomer #2 | CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)C1=CC=C(F)C=C1 | 4719.2 | Standard polar | 33892256 | Ilginatinib,2TBDMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 3754.9 | Semi standard non polar | 33892256 | Ilginatinib,2TBDMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 3735.5 | Standard non polar | 33892256 | Ilginatinib,2TBDMS,isomer #1 | CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 4473.5 | Standard polar | 33892256 |
|
---|